ArticleVeterinary dermatology2026
Phylogenetic and Structural Analysis of Miconazole Susceptibility in Malassezia pachydermatis Isolates From Dogs With Otitis Externa.
Article in Veterinary dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global transcriptomic response ofFrontiers in veterinary science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAn increased number of dogs with unresolved yeast otitis externa (OE) after miconazole treatment was observed at a tertiary practice. HYPOTHESIS/
objectivesTo evaluate miconazole susceptibility in Malassezia pachydermatis isolates from canine OE. ANIMALS: Eleven client-owned dogs (16 ears) with clinical and video otoscopic signs of OE and cytological evidence of yeast. MATERIALS AND
methodsYeast cultures were derived from ear swabs. PCR amplified portions of the internal transcribed spacer region (ITS), and partial sequences encoding the 18S rRNA small subunit (SSU), 26S rRNA large subunit (LSU), and actin (ACT1) loci for phylogenetic analysis, as well as the ERG11 gene that encodes lanosterol 14α-demethylase. Miconazole susceptibility was assessed by disk diffusion on Mueller-Hinton agar. Molecular modelling was used to evaluate the relationship between lanosterol 14α-demethylase amino acid substitutions and miconazole susceptibility.
resultsIsolates of M. pachydermatis from canine OE formed a three-clade phylogeny. Most ERG11 mutations predicted lanosterol 14α-demethylase substitutions that were clade-specific without an effect on miconazole susceptibility. Reduced susceptibility was associated with substitutions of amino acid A302, located in the lanosterol 14α-demethylase azole-binding site. Other altered amino acids were located elsewhere in the lanosterol 14α-demethylase protein without an apparent effect on miconazole binding. CONCLUSIONS AND CLINICAL RELEVANCE: Clinical isolates of M. pachydermatis with reduced miconazole susceptibility were easily found, suggesting that miconazole resistance is present in routine patients. Lanosterol 14α-demethylase interactions with longer-tailed azoles involve additional contacts beyond A302 suggesting these drugs will be more effective against miconazole-resistant strains. However, effective antifungal stewardship is needed to slow development of pan-azole resistance that would limit treatment options for dogs with M. pachydermatis-associated disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.